Saunders Brent L
- SEC CIK
- 0001268854
In the past year, 1 open-market purchase filing worth $252.0K and no sales.
Current role at each company
- BLCO Bausch & Lomb CorpChairman of the Board and CEOas of Aug 7, 2026
- SPRY ARS Pharmaceuticals, Inc.Directoras of Jun 26, 2026
- SKIN SkinHealth Systems Inc.Director, Other: Chairmanas of Jun 18, 2025
- CSCO Cisco Systems, Inc.Directoras of Dec 12, 2022
- BBIO BridgeBio Pharma, Inc.Directoras of Jun 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $252.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$252.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Saunders Brent L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BLCO Bausch & Lomb Corp
Chairman of the Board and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 (view filing) | Mar 6 | 4 days | Saunders Brent LCEO and Chairman of the Board | PPurchaseCommon Shares, No Par Value | +14.7K | $17.14 | +$252.0K | +1.5%966.6K after | |
| May 27, 2025 (view filing) | May 22 | 5 days | Saunders Brent LCEO and Chairman of the Board | PPurchaseCommon Shares, No Par Value | +22.0K | $11.28 | +$248.2K | +3.2%719.2K after | |
| Aug 7, 2024 (view filing) | Aug 5 | 2 days | Saunders Brent LCEO and Chairman of the Board | PPurchaseCommon Shares, No Par Value | +32.3K | $15.66 | +$505.0K | +5.7%595.2K after |
SPRY ARS Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 (view filing) | May 20 | 2 days | Saunders Brent LDirector | SSale | −120.0K | $14.25 | −$1.71M | −100.0%0 after |
SKIN SkinHealth Systems Inc.
Director, Other: Chairman2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2024 (view filing) | Aug 12 | 1 day | Saunders Brent LDirector, Other: Chairman | PPurchaseClass A Common Stock | +40.5K | $1.08 | +$43.7K | +0.7%5.92M after | |
| Aug 17, 2023 (view filing) | Aug 16 | 1 day | Saunders Brent LDirector, Other: Chairman | PPurchaseClass A Common Stock | +59.4K | $6.10 | +$362.2K | +1.0%5.83M after |
BBIO BridgeBio Pharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 (view filing) | Dec 29, 2021 | 5 days | Saunders Brent LDirector | PPurchase | +17.6K | $14.48 | +$254.8K | New position17.6K after |